Copyright
©The Author(s) 2024.
World J Methodol. Jun 20, 2024; 14(2): 92612
Published online Jun 20, 2024. doi: 10.5662/wjm.v14.i2.92612
Published online Jun 20, 2024. doi: 10.5662/wjm.v14.i2.92612
Gastric and oesophageal cancer, all results presented as n (%) unless specified | Gastric, n = 5 | Oesophagus, n = 2 | |
Overall complications | Mortality (CD V) | 0 (0) | 1 (50.0) |
Patients with complications | 1 (20.0) | 2 (100.0) | |
Unplanned critical care admission (CD IV) | 0 | 0 | |
Planned ICU admission | 2 (40.0) | 2 (100.0) | |
Reintervention (CD III) | 0 | 1 (50.0) – IIIa (stent) | |
Any major complication (CD III-V) | 0 | 2 (100.0) | |
Acute kidney injury | 2 (100.0) | ||
Pulmonary embolism | 1 (50.0) | ||
Septic shock | 1 (50.0) | ||
Anastomotic leak | 2 (100.0) | ||
Ileus | 0 | ||
Bleeding requiring transfusion | 0 | 0 | |
Superficial/deep SSI | 1 (20.0) | 1 (50.0) | |
Other | 1 (20.0)1 | 1 (50.0)2 | |
Length of stay (d) | Mean (SD) | 8.4 (3.13) | 14 (7.7) |
- Citation: Trébol J, Carabias-Orgaz A, Esteban-Velasco MC, García-Plaza A, González-Muñoz JI, Sánchez-Casado AB, Parreño-Manchado FC, Eguía-Larrea M, Alcázar-Montero JA. Digestive and breast cancer patients managed during the first wave of COVID-19 pandemic: Short and middle term outcomes. World J Methodol 2024; 14(2): 92612
- URL: https://www.wjgnet.com/2222-0682/full/v14/i2/92612.htm
- DOI: https://dx.doi.org/10.5662/wjm.v14.i2.92612